Recently, one study explored the core molecular mechanism and found that stearoyl-coenzyme A desaturase-1 (SCD1) expression was downregulated in T2DM patients, and decreased SCD1 reduced the osteogenic differentiation of BMSCs by activating the miR-203a/FOS and miR-1908/EXO1 regulatory pathways (Chen Y.S. et al., 2020). This evidence concerns the gene SCD and type 2 diabetes mellitus.